UI
DW-UI BIO TECHNOLOGY & ANALYTICS RESEARCH CENTER
The Biotechnology and Bioanalysis Research Institute is dedicated to establishing Indonesia's bio-industrial infrastructure through advanced research in proteins, cell therapy, organoids, and gene editing. It also provides specialized biopharmaceutical analysis training to cultivate highly skilled local talent.
The Biotechnology and Bioanalysis Research Institute is dedicated to establishing Indonesia's bio-industrial infrastructure through advanced research in proteins, cell therapy, organoids, and gene editing. It also provides specialized biopharmaceutical analysis training to cultivate highly skilled local talent.
R&D Projects
Collaborative Network
Through strategic collaboration among three premier research institutions—ITB, UI, and IPB—the initiative aims to enhance research capabilities and establish a globally competitive hub for advanced biotechnology research and biomanufacturing in Indonesia. It strives to deliver innovative therapeutic solutions in the fields of pharmaceuticals and stem cell therapy, while also identifying and nurturing top-tier research talent within Indonesia's bio sector.
Areas of Specialization by Research Institute
- UI (University of Indonesia): Specializes in biotechnology research and bioanalysis- ITB (Bandung Institute of Technology): Focuses on formulation and drug delivery technologies- IPB (Bogor Agricultural University): Concentrates on non-clinical studies using primates
Integrated Research Ecosystem
Each institute leverages its unique expertise to form a synergistic network, facilitating an integrated research environment that spans formulation development, preclinical testing, and biotechnological research and analysis.
UI Biotechnology Research Center
.jpeg)
Established through a strategic partnership between Daewoong Pharmaceutical Company Indonesia (DPCI) and Universitas Indonesia (UI) in 2017, the Daewoong-UI Biotechnology Research Center was officially launched in April 2018.
The center leads advanced biopharmaceutical research in Indonesia, focusing on cutting-edge technologies such as stem cell therapy, gene editing, and organoid-based alternative testing. The portfolio includes formulation upgrades and stability studies for key biologics products, as well as immunogenicity assessments and protein purification process optimization. In addition to research, the center actively contributes to talent development since 2018, offering workshops and training programs for students from UI and ITB.
The center leads advanced biopharmaceutical research in Indonesia, focusing on cutting-edge technologies such as stem cell therapy, gene editing, and organoid-based alternative testing. The portfolio includes formulation upgrades and stability studies for key biologics products, as well as immunogenicity assessments and protein purification process optimization. In addition to research, the center actively contributes to talent development since 2018, offering workshops and training programs for students from UI and ITB.
UI Bioanalytical Laboratory
Launched in August 2022, the UI-Daewoong Bioanalytical Laboratory is a state-of-the-art facility dedicated to the analysis of biological samples critical for biopharmaceutical development, including proteins and cell-based materials.
The lab supports Good Laboratory Practice (GLP) and ISO 17025 certification preparation, Halal facility readiness, and collaborative research initiatives with academic and industrial partners.
With a strong focus on regenerative and advanced therapies, the lab plays a vital role in enabling the development of innovative treatments such as cell and gene therapies.
Since 2022, the laboratory has also contributed to workforce development by offering structured internship and practice programs for students from UI.
The lab supports Good Laboratory Practice (GLP) and ISO 17025 certification preparation, Halal facility readiness, and collaborative research initiatives with academic and industrial partners.
With a strong focus on regenerative and advanced therapies, the lab plays a vital role in enabling the development of innovative treatments such as cell and gene therapies.
Since 2022, the laboratory has also contributed to workforce development by offering structured internship and practice programs for students from UI.
Biologics Optimization
Conducting formulation and stability studies to enhance the quality, efficacy, and shelf-life of biopharmaceutical products.
Purification Process Improvement
Evaluating purification materials and methodologies to improve manufacturing efficiency and consistency.
Immunogenicity Assessment
Developing analytical assays to evaluate the safety and immune response profiles of biologics.
Advanced Therapeutics Research
Exploring cutting-edge platforms such as stem cell therapy, gene editing, and organoid-based alternatives to animal testing.
Academic Collaboration & Talent Development
Supporting student workshops, training, and internships in partnership with UI, with over 280 applicants to the 2024 research program alone.
